Juq-158 Now

Below are a few that are both interesting and well‑cited, covering a range of topics you might find useful for a course or research project labeled “JUQ‑158.” (If you can share a bit more about the discipline—e.g., quantum computing, sociology, environmental science, etc.—I can narrow the list even further.)

| Target | Activity (reported) | Comments | |--------|----------------------|----------| | | Partial agonist (EC₅₀ ≈ 120 nM) | Comparable to some phenethylamine psychedelics; functional selectivity toward β‑arrestin pathways was suggested. | | Dopamine transporter (DAT) | Inhibitor (IC₅₀ ≈ 250 nM) | Potency sits between typical stimulants (cocaine ≈ 150 nM) and weaker inhibitors (bupropion ≈ 600 nM). | | Norepinephrine transporter (NET) | Weak inhibition (IC₅₀ ≈ 1.2 µM) | Likely not a major contributor to acute effects. | | CB₁ / CB₂ receptors | No measurable binding (< 10 µM) | Unlike many synthetic cannabinoids, JUJ‑158 does not appear to act on the endocannabinoid system. | | σ₁ receptor | Moderate binding (Kᵢ ≈ 350 nM) | May influence neuroprotective or psychotomimetic properties, but data are preliminary. | JUQ-158

This document is intended for informational and educational purposes only. It does not constitute medical, legal, or safety advice, and it is not a recommendation for any kind of use. If you are a researcher, always follow institutional, local, and national regulations regarding controlled substances, novel chemicals, and laboratory safety. Below are a few that are both interesting

Below is an informative draft exploring the broader context of such alphanumeric identifiers and how they function as modern archival tools. | | CB₁ / CB₂ receptors | No